Skip to content

Review, 2002

Does the new oral contraceptive Yasmin improve premenstrual symptoms and well-being?

Yes. Women with premenstrual symptoms who took Yasmin showed improved well-being scores and fewer physical symptoms compared to before starting the medication.

Moderate study design Women wanting contraception, including 100 in a European study examining well-being.

What they did

This is a review of studies on Yasmin, a new oral contraceptive. One European study assessed the effects over 6 treatment cycles in women wanting contraception.

What they found

Women who reported premenstrual symptoms before starting Yasmin had improved Psychological General Well-Being Index scores and suffered fewer somatic symptoms. Acne lesion count decreased by 62.5% from baseline to cycle 9. Seborrhea decreased by 25.1%.

What it means for you

For women with premenstrual symptoms, this pill may improve both mood and physical symptoms and help with skin. This is a review of multiple studies rather than a single new experiment.

62.5%

decrease in acne lesions by cycle 9

25.1%

decrease in seborrhea

6

number of treatment cycles studied

About the study

Original title
Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being
Authors
Mansour D
Journal
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Year
2002
Study design
Review
What was tested
DRSP/EE (Yasmin) oral contraceptive containing 3 mg drospirenone and 30 micrograms ethinylestradiol

Topics